NO20044092L - Oftalmisk sammensetning som innbefatter ascomycin - Google Patents

Oftalmisk sammensetning som innbefatter ascomycin

Info

Publication number
NO20044092L
NO20044092L NO20044092A NO20044092A NO20044092L NO 20044092 L NO20044092 L NO 20044092L NO 20044092 A NO20044092 A NO 20044092A NO 20044092 A NO20044092 A NO 20044092A NO 20044092 L NO20044092 L NO 20044092L
Authority
NO
Norway
Prior art keywords
ascomycin
composition including
ophthalmic composition
ophthalmic
including ascomycin
Prior art date
Application number
NO20044092A
Other languages
English (en)
Inventor
Shau-Fong Yen
Michelle Pik-Han Wong
Maggy Babiole Saunier
Jean-Claude Bizec
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044092(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20044092L publication Critical patent/NO20044092L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20044092A 2002-03-04 2004-09-27 Oftalmisk sammensetning som innbefatter ascomycin NO20044092L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36151502P 2002-03-04 2002-03-04
US40927502P 2002-09-09 2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en) 2002-03-04 2003-03-03 Ophthalmic composition comprising ascomycin

Publications (1)

Publication Number Publication Date
NO20044092L true NO20044092L (no) 2004-09-27

Family

ID=27791682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044092A NO20044092L (no) 2002-03-04 2004-09-27 Oftalmisk sammensetning som innbefatter ascomycin

Country Status (28)

Country Link
US (4) US20050220823A1 (no)
EP (1) EP1482936B1 (no)
JP (1) JP4740542B2 (no)
KR (1) KR100992948B1 (no)
CN (1) CN1297270C (no)
AR (1) AR038628A1 (no)
AT (1) ATE341326T1 (no)
AU (1) AU2003218679B2 (no)
BR (1) BR0308184A (no)
CA (1) CA2477769C (no)
CO (1) CO5611133A2 (no)
DE (1) DE60308836T2 (no)
DK (1) DK1482936T3 (no)
EC (1) ECSP045277A (no)
EG (1) EG24403A (no)
ES (1) ES2274214T3 (no)
HK (1) HK1071301A1 (no)
IL (2) IL163657A0 (no)
MX (1) MXPA04008571A (no)
MY (1) MY137563A (no)
NO (1) NO20044092L (no)
NZ (1) NZ534690A (no)
PE (1) PE20030828A1 (no)
PL (1) PL210870B1 (no)
PT (1) PT1482936E (no)
RU (1) RU2322982C2 (no)
TW (1) TW200305437A (no)
WO (1) WO2003074054A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL206594B1 (pl) 2002-07-15 2010-08-31 Alcon Kompozycja implantu śródocznego i zastosowanie leku oftalmicznego w połączeniu z niskocząsteczkowym związkiem lipofilowym do jej wytwarzania
WO2004009056A1 (en) * 2002-07-23 2004-01-29 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (en) 2009-04-09 2010-10-13 Nestec S.A. Beverage preparation device having a closing mechanism with force demultiplying means
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
PT2429510E (pt) * 2009-05-12 2015-10-12 Galenica Ab Emulsão de óleo em água de mometasona e propilenglicol
JP5779591B2 (ja) * 2009-12-22 2015-09-16 アッヴィ・インコーポレイテッド Ａｂｔ−２６３カプセル剤
JP2013523828A (ja) * 2010-04-07 2013-06-17 アラーガン インコーポレイテッド 眼科用組成物のための保存剤の組み合わせ
RU2531937C2 (ru) * 2012-05-14 2014-10-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазной мази
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
AU2013384818A1 (en) * 2013-03-27 2015-11-12 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
JP6448545B2 (ja) * 2013-11-29 2019-01-09 ロート製薬株式会社 眼科用又は耳鼻科用水性組成物
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US10606760B2 (en) * 2017-08-23 2020-03-31 Samsung Electronics Co., Ltd. Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU635286B2 (en) * 1989-07-05 1993-03-18 Astellas Pharma Inc. Aqueous liquid composition for external use
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
US5496811A (en) * 1992-08-28 1996-03-05 Pharmos Corp. Submicron emulsions as ocular drug delivery vehicles
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
DE69426062T2 (de) * 1993-08-18 2001-03-22 Alcon Lab Inc Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
AU3609795A (en) * 1994-10-10 1996-05-02 Novartis Ag Ophthalmic and aural compositions containing diclofenac potassium
DK1147766T3 (da) * 1994-10-26 2005-08-29 Novartis Ag Farmaceutiske sammensætninger
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
FR2755852B1 (fr) * 1996-11-15 1998-12-24 Oreal Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
CN1161117C (zh) * 1998-04-27 2004-08-11 藤泽药品工业株式会社 药物组合物
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
EP1173177B2 (en) * 1999-04-30 2014-03-05 Sucampo AG Use of macrolide compounds for the treatment of dry eye

Also Published As

Publication number Publication date
NZ534690A (en) 2007-06-29
MXPA04008571A (es) 2004-12-06
PL210870B1 (pl) 2012-03-30
ATE341326T1 (de) 2006-10-15
US20110152307A1 (en) 2011-06-23
EP1482936B1 (en) 2006-10-04
EG24403A (en) 2009-04-29
WO2003074054A1 (en) 2003-09-12
CO5611133A2 (es) 2006-02-28
IL163657A0 (en) 2005-12-18
RU2004129593A (ru) 2005-09-10
EP1482936A1 (en) 2004-12-08
DK1482936T3 (da) 2007-01-08
CN1297270C (zh) 2007-01-31
TW200305437A (en) 2003-11-01
AU2003218679B2 (en) 2007-04-05
ES2274214T3 (es) 2007-05-16
PT1482936E (pt) 2007-01-31
CN1638769A (zh) 2005-07-13
US20120015971A1 (en) 2012-01-19
KR100992948B1 (ko) 2010-11-08
JP2005529851A (ja) 2005-10-06
RU2322982C2 (ru) 2008-04-27
PE20030828A1 (es) 2003-11-04
US20050220823A1 (en) 2005-10-06
CA2477769C (en) 2011-01-18
AU2003218679A1 (en) 2003-09-16
MY137563A (en) 2009-02-27
KR20040094718A (ko) 2004-11-10
HK1071301A1 (en) 2005-07-15
JP4740542B2 (ja) 2011-08-03
CA2477769A1 (en) 2003-09-12
DE60308836D1 (de) 2006-11-16
BR0308184A (pt) 2005-01-11
IL163657A (en) 2009-11-18
AR038628A1 (es) 2005-01-19
PL370917A1 (en) 2005-06-13
US20100113501A1 (en) 2010-05-06
DE60308836T2 (de) 2007-04-26
ECSP045277A (es) 2004-10-26

Similar Documents

Publication Publication Date Title
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
NO20040775L (no) Oftalmisk sammensetning som innbefatter et askomycin
DE60312054D1 (de) Prothese
ATE450506T1 (de) Indol-3-schwefelderivate
ATE438644T1 (de) Chinazolinderivate
DE602004031845D1 (de) Ng
HK1071301A1 (en) Ophthalmic composition comprising ascomycin
DE10393374D2 (de) Zusammensetzung
BRPI0313075A2 (pt) composições de vidro
DE502004010381D1 (de) Um
SE0500163L (sv) Sammansättning
DE60306259D1 (de) Auswuchtgerät
ATE335729T1 (de) 3h-chinazoline -4-on derivaten
DK1492934T3 (da) Dørenhed
DK1556377T3 (da) Cyclopropylthienylcarboxamider som fungicider
ATE423771T1 (de) Tetrahydrochinolinderivate
DE60322421D1 (de) Verbesserter brillenbügel
DE602004018799D1 (de) Ng
EP1661573A4 (en) OPHTHALMIC COMPOSITION
DE50307217D1 (de) Glaskörper
EP1647273A4 (en) OPHTHALMIC COMPOSITION
ITMI20031187A1 (it) Astuccio per occhiali
NO20044140D0 (no) New Composition
DE60333472D1 (de) Kautschukzusammensetzung
NO20053110D0 (no) 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application